Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Mediated”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableAvailableNCT07780110
What this trial is testing

Compassionate Use of Vonsetamig

Who this might be right for
Plasma Cell MediatedAntibody Mediated
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02420223
What this trial is testing

Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 25
Early research (Phase 1)Active Not RecruitingNCT06369467
What this trial is testing

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

Who this might be right for
Food Allergy
Regeneron Pharmaceuticals 6
Not applicableNot Yet RecruitingNCT07277998
What this trial is testing

Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis

Who this might be right for
Oral Submucous Fibrosis
Karachi Medical and Dental College 40
Not applicableUnknownNCT03776331
What this trial is testing

Vascular Functions in Myeloma Patients During Anti-tumor Therapy

Who this might be right for
CardiooncologyMyelomaEndothelial Dysfunction
University Hospital, Essen 96
Post-approval studies (Phase 4)Ended earlyNCT00819832
What this trial is testing

Anderson Circulating Tumor Cell Burden (CTCB) Study

Who this might be right for
CancerSpinal DiseaseVertebral Compression Fractures
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05065554
What this trial is testing

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Who this might be right for
IgM MGUSWaldenstrom MacroglobulinemiaNeuropathy;Peripheral
Shayna Sarosiek, MD 12
Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Not applicableStudy completedNCT07614243
What this trial is testing

Long Non-coding RNA (lncRNA) ZFAS1-Mediated Mechanism of Roasted Nux Vomica in Intervening Bortezomib-Induced Peripheral Neuropathy

Who this might be right for
Multiple MyelomaChemotherapy-Induced Peripheral Neuropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 22
Testing effectiveness (Phase 2)WithdrawnNCT06050512
What this trial is testing

Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Kathleen Dorritie
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00399867
What this trial is testing

Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
Ludwig-Maximilians - University of Munich 30